Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 639 of 1,261

  1. US 9624170

    4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  2. US 9623035

    Triptolide prodrugs

    Regents of the University of Minnesota · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  3. US 9624233

    Compounds for treating pruritic conditions

    Trevi Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  4. WO 2017060524

    (E)-N-(2-AMINOPHÉNYL)-3-(1-((4-(1-MÉTHYL-1H-PYRAZOL-4-YL)PHÉNYL)SULFONYL)-1H-PYRROL-3-YL)ACRYLAMIDE POUR LE TRAITEMENT D'INFECTIONS VIRALES LATENTES

    4SC AG [DE] · Granted Apr 13, 2017 · Expires Apr 8, 2037

    granted

  5. CA 3000894

    TRAITEMENT DE LA MASTOCYTOSE SYSTEMIQUE GRAVE PAR LE MASITINIB

    AB SCIENCE [FR] · Granted Apr 13, 2017 · Expires Apr 8, 2037

    granted

  6. AR 103028

    COMPUESTOS ANTIBACTERIANOS CON ACCIÓN SOBRE TOPOISOMERASAS

    ACRAF [IT] · Granted Apr 12, 2017 · Expires Apr 7, 2037

    granted

  7. US 9616047

    Inhibitors of beta-catenin in treatment of colorectal cancer

    Regents of the University of Minnesota · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  8. US 9616140

    Fluorescent phospholipid ether compounds, compositions, and methods of use

    CELLECTAR BIOSCIENCES, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  9. US 9616048

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  10. US 9616107

    Therapy for kidney disease and/or heart failure

    Capricor Therapeutics, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  11. US 9616115

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  12. US 9617305

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  13. US 9617512

    Derivation of embryonic stem cells and embryo-derived cells

    Astellas Institute for Regenerative Medicine · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  14. US 9618521

    Sperm-specific cation channel, Catsper2, and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  15. US 9617229

    Phenylmorpholines and analogues thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  16. US 9616139

    Conjugating amines

    The United States, as represented by the Secretary Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  17. US 9617228

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  18. US 9617539

    Modulation of UBE3A-ATS expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  19. US 9617303

    Sustained-release composition and method for producing the same

    Takeda Pharmaceutical Company Limited · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  20. US 9617268

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  21. US 9617203

    Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

    VANDA PHARMACEUTICALS INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  22. US 9617511

    Tissue-specific differentiation matrices and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  23. US 9616113

    Peptide conjugated particles

    Northwestern University · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  24. US 9616116

    Detoxified endotoxin immunogenic compositions and uses thereof

    United States Army · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.